(Q52915496)

9 May 2018

title

Relevance of osteoproliferation as an outcome parameter in ankylosing spondylitis. (English)

1 reference

9 May 2018

author name string

Heiner Appel

series ordinal

1

1 reference

9 May 2018

Martin Rudwaleit

series ordinal

2

1 reference

9 May 2018

Joachim Sieper

series ordinal

3

1 reference

9 May 2018

publication date

7 October 2008

1 reference

9 May 2018

Nature Clinical Practice Rheumatology

published in

1 reference

9 May 2018

volume

4

1 reference

9 May 2018

issue

11

1 reference

9 May 2018

page(s)

578-579

1 reference

9 May 2018

cites work

Ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0930

7 January 2021

Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0930

7 January 2021

Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0930

7 January 2021

Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0930

7 January 2021

Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0930

7 January 2021

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0930

7 January 2021

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0930

7 January 2021

Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0930

7 January 2021

Dickkopf-1 is a master regulator of joint remodeling

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0930

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0930

1 reference

9 May 2018

PubMed ID

18839009

1 reference

9 May 2018